These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15098848)

  • 1. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
    Malone DC; Abarca J; Hansten PD; Grizzle AJ; Armstrong EP; Van Bergen RC; Duncan-Edgar BS; Solomon SL; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):142-51. PubMed ID: 15098848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A; Ludányi Z; Erdős Á; Botz L
    BMC Pharmacol Toxicol; 2019 May; 20(1):36. PubMed ID: 31151485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy managers' perception of computerized drug-drug interaction alerts.
    Abarca J; Malone DC; Skrepnek GH; Rehfeld RA; Murphy JE; Grizzle AJ; Armstrong EP; Woosley RL
    J Am Pharm Assoc (2003); 2006; 46(2):148-53. PubMed ID: 16602224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC; Glassman PA; Marks IR; Fowler C; Castiglione B; Good CB
    J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication dispensing errors in Palestinian community pharmacy practice: a formal consensus using the Delphi technique.
    Shawahna R; Haddad A; Khawaja B; Raie R; Zaneen S; Edais T
    Int J Clin Pharm; 2016 Oct; 38(5):1112-23. PubMed ID: 27365093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study.
    Bakker T; Klopotowska JE; de Keizer NF; van Marum R; van der Sijs H; de Lange DW; de Jonge E; Abu-Hanna A; Dongelmans DA;
    J Crit Care; 2020 Jun; 57():134-140. PubMed ID: 32145656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An International Consensus List of Potentially Clinically Significant Drug-Drug Interactions in Older People.
    Anrys P; Petit AE; Thevelin S; Sallevelt B; Drenth C; Soiza RL; Correa-Pérez A; Dalleur O; De Brauwer I; Petrovic M; Coleman JJ; Dalton K; O'Mahony D; Löwe A; Thürig S; Gudmundsson A; Cherubini A; Panos A; Mavridis D; Rodondi N; Spinewine A
    J Am Med Dir Assoc; 2021 Oct; 22(10):2121-2133.e24. PubMed ID: 33901428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interactions within Veterans Affairs medical centers.
    Mahmood M; Malone DC; Skrepnek GH; Abarca J; Armstrong EP; Murphy JE; Grizzle AJ; Ko Y; Woosley RL
    Am J Health Syst Pharm; 2007 Jul; 64(14):1500-5. PubMed ID: 17617500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment tool for pharmacy drug-drug interaction software.
    Warholak TL; Hines LE; Saverno KR; Grizzle AJ; Malone DC
    J Am Pharm Assoc (2003); 2011; 51(3):418-24. PubMed ID: 21555296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of computerized alerts with management strategies for 25 serious drug-drug interactions.
    Murphy JE; Malone DC; Olson BM; Grizzle AJ; Armstrong EP; Skrepnek GH
    Am J Health Syst Pharm; 2009 Jan; 66(1):38-44. PubMed ID: 19106343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions.
    Magro L; Moretti U; Leone R
    Expert Opin Drug Saf; 2012 Jan; 11(1):83-94. PubMed ID: 22022824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.
    Solberg LI; Hurley JS; Roberts MH; Nelson WW; Frost FJ; Crain AL; Gunter MJ; Young LR
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):753-9. PubMed ID: 15623265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.